Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
55.2M
-
Number of holders
-
104
-
Total 13F shares, excl. options
-
25.6M
-
Shares change
-
+2.98M
-
Total reported value, excl. options
-
$293M
-
Value change
-
+$48.1M
-
Put/Call ratio
-
0.51
-
Number of buys
-
75
-
Number of sells
-
-36
-
Price
-
$11.45
Significant Holders of Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) as of Q2 2023
128 filings reported holding VYGR - Voyager Therapeutics, Inc. - Common Stock, $0.001 par value as of Q2 2023.
Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) has 104 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 25.6M shares
of 55.2M outstanding shares and own 46.43% of the company stock.
Largest 10 shareholders include EcoR1 Capital, LLC (3.85M shares), ARMISTICE CAPITAL, LLC (3.62M shares), BlackRock Inc. (2.48M shares), VANGUARD GROUP INC (2.48M shares), FARALLON CAPITAL MANAGEMENT LLC (1.29M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.23M shares), Erste Asset Management GmbH (1.06M shares), D. E. Shaw & Co., Inc. (948K shares), MORGAN STANLEY (783K shares), and ACADIAN ASSET MANAGEMENT LLC (720K shares).
This table shows the top 104 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.